ClinicalTrials.Veeva

Menu

Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone

H

Hvidovre University Hospital

Status

Unknown

Conditions

HIV-Associated Lipodystrophy Syndrome
HIV Infections

Study type

Observational

Funder types

Other

Identifiers

NCT00662181
H-B-2008-053
2008-41-2145

Details and patient eligibility

About

A follow-up study on the randomized, controlled, double-blind HIGH: low study. We will examine the participants from the HIGH: low study min. 6 months after finishing the HIGH: low study. We will look at the parameters: quality of life, sugar-metabolism, fat-metabolism, fat-redistribution and cytokines. The study will use the participants control visit, and the only additional examination will be the danish MOS-HIV questionnaire.

Enrollment

46 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • over 18 years of age
  • Participated in and completed the HIGH: low study
  • informed consent signed

Exclusion criteria

  • Patient stopped at Hvidovre Hospital, or didn't finish the HIGH: low study

Trial design

46 participants in 1 patient group

H, NH
Description:
HIV positive patients with and without lipodystrophy

Trial contacts and locations

1

Loading...

Central trial contact

Katrine MH Andersen, stud.med.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems